Berberine improves the intestinal antioxidant status of laboratory mice, Mus musculus  by Dkhil, Mohamed A. et al.
Saudi Journal of Biological Sciences (2015) xxx, xxx–xxxKing Saud University
Saudi Journal of Biological Sciences
www.ksu.edu.sa
www.sciencedirect.comORIGINAL ARTICLEBerberine improves the intestinal antioxidant status
of laboratory mice, Mus musculus* Corresponding author at: Department of Zoology, College of
Science, King Saud University, P.O. Box: 2455, Riyadh 11451, Saudi
Arabia. Tel.: +966 14675754; fax: +966 14678514.
E-mail address: mohameddkhil@yahoo.com (M.A. Dkhil).
Peer review under responsibility of King Saud University.
Production and hosting by Elsevier
http://dx.doi.org/10.1016/j.sjbs.2015.10.012
1319-562X  2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Please cite this article in press as: Dkhil, M.A. et al., Berberine improves the intestinal antioxidant status of laboratory mice, Mus musculus. Saudi Journa
logical Sciences (2015), http://dx.doi.org/10.1016/j.sjbs.2015.10.012Mohamed A. Dkhil a,b,*, Mahmoud S. Metwaly a, Saleh Al-Quraishy aaDepartment of Zoology, College of Science, King Saud University, Riyadh, Saudi Arabia
bDepartment of Zoology and Entomology, Faculty of Science, Helwan University, Cairo, EgyptReceived 17 August 2015; revised 10 October 2015; accepted 18 October 2015KEYWORDS
Mice;
Berberine;
Oxidative damage;
Antioxidants;
ApoptosisAbstract Oral administration of berberine chloride to mice induced an obvious enhancement in
jejunal health status as expressed by the significant reduction of apoptotic cells within the intestinal
villi from 15.5 to 8.3 apoptotic cell/10 VCU. In addition, jejunal antioxidant biomarkers were
significantly improved as revealed by the increase in the activities of catalase and glutathione per-
oxidase enzymes with a concurrent increase in reduced glutathione levels and total antioxidant
capacity. Also, it was associated with a significant decrease in oxidative damage biomarkers of
hydrogen peroxides, malondialdehyde, nitrite/nitrate, inducible nitric oxide synthase and protein
carbonyl content. Moreover, BBR treatment induced a reduction in the pro-inflammatory cytokine,
TNF-a by about 40%. It is highly recommended to use berberine as food supplements or as natural
drug therapy to enhance the antioxidant status within the intestinal tissue.
 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Normal human and animal diet contains a wide range of var-
ious pro-oxidants formed during food preparation for cook-
ing. It includes oxidized polyunsaturated fatty acids,
oxysterols, nitrites, nitrates, heavy metals, mycotoxins and
many other organic pollutants. These harmful substances arefound in food in low levels; however, various combinations
of these pro-oxidants in food are considered to be the source
of free radical production in the gastrointestinal tract (GIT).
Therefore effective antioxidant protection in the GIT is needed
to maintain gut health and this protection is based on food
derived or supplemented antioxidants (Surai et al., 2003,
2004).
Berberine is an isoquinoline alkaloid, present in root and
shoot systems of clinically important medicinal plants
(Timothy et al., 1997). Berberine based products are widely
applied in traditional medicine (Wongbutdee, 2008). It has
been known to have a wide range of pharmacological activities
due to its non-toxic effect on humans (Vuddanda et al., 2010).
Many studies were carried out to use berberine against
several diseases for the in vivo mammalian system (Dkhil,
2014; Malik et al., 2014; Dkhil et al., 2015). Moreover,
Previous studies showed that, berberine has a wide range ofl of Bio-
2 M.A. Dkhil et al.antioxidant activities including activation of the antioxidant
enzyme (Siow et al., 2011).
This study aims to test the effect of berberine treatment in
enhancing the antioxidant status within mouse jejunum tissue.
2. Materials and methods
2.1. Animals
Twelve male Swiss albino mice, Mus musculus (9–11 weeks)
were allocated randomly into two groups with 6 mice per
group. The first group is considered as the control group which
received saline. The second group was daily treated with 10 mg/kg
berberine chloride (Sigma Company, St. Louis, MO, USA) for
five successive days via oral gavaging using an epigastric tube.
The experiment was approved by state authorities of Zoology
Department at King Saud University. The used dose is in
agreement with previous studies on cytotoxicity measurements
(Timothy et al., 1997; Jahnke et al., 2006).
2.2. Sample collection
Animals were killed by cervical dislocation at day 5 p.i. Jejunum
tissue was separated and washed several times with ice cold ster-
ile phosphate buffer saline and divided into different portions.
2.3. Immunohistochemical staining of apoptosis and apoptotic
score
Jejunum was isolated and cut into small pieces, then fixed in
10% neutral buffered formalin. After fixation, specimens were
dehydrated in ethanol then, embedded in paraffin wax.
Jejunum was sectioned to 5 l thickness. Jejunum sections were
tested for apoptotic changes in their villi using the TUNEL
Apoptosis detection kit (GenScript, USA). The test is based
on detection of fragmented DNA in the nucleus during apop-
tosis. Biotinylated nucleotide is labeled at the DNA 30-OH
ends using terminal deoxynucleotidyl transferase (TDT). Then,
horseradish peroxidase labeled streptavidin (Streptavidin-
HRP) is bound to these biotinylated nucleotides, which detect
the peroxidase substrate, H2O2, and 3,3
0-diaminobenzidine
(DAB) solution staining the apoptotic nuclei dark brown
color. Sections were then counterstained with hematoxylin
solution for 1 min before the final processing of slides (Dkhil
et al., 2013). Apoptotic score was determined via counting
the average number of apoptotic cells for ten better-
orientated villous crypt units (VCU). Results were presented
as the mean number of apoptotic cells per ten VCU.
2.4. Preparation of tissue homogenate
Pieces of jejunum were weighed then immediately homoge-
nized in ice-cold phosphate buffered saline then centrifuged
at 2000g  15 min at 4 C to give a final yield of (10% w/v)
jejunal homogenates that were kept at 20 C until use.
2.5. Oxidative damage biomarkers in jejunal homogenates
Oxidized proteins were determined via the estimation of pro-
tein carbonyl content through the formation of labeled proteinPlease cite this article in press as: Dkhil, M.A. et al., Berberine improves the intesti
logical Sciences (2015), http://dx.doi.org/10.1016/j.sjbs.2015.10.012hydrazone derivatives using 2,4-dinitro phenyl hydrazine
(Levine et al., 1990), while, malondialdehyde was determined
via the reaction with thiobarbituric acid in an acidic medium
and high temperature yielding a colored product with a color
intensity directly proportional to the amount of MDA at
534 nm (Ohkawa et al., 1979). In addition, hydrogen peroxide
level was measured after the reaction with peroxidase enzyme,
and with 3,5-dichloro-2-hydroxybenzensulfonic acid and
4-aminophenazone to form a chromophore with color inten-
sity directly proportional to the amount of hydrogen peroxides
in the test samples at 540 nm (Aebi, 1984). Moreover, nitrite/
nitrate levels were determined via the formation of nitrous acid
diazotise sulfanilamide in an acidic medium and the products
were coupled with N-(1-naphthyl) ethylenediamine. The
formed azo dye appeared bright reddish-purple in color that
can be measured at 540 nm (Berkels et al., 2004).
TNF-a level and iNOs activity were determined using anti-
gen antibody interaction in 96-microplate wells coated with
specific monoclonal antibodies. Tumor necrosis factor-a was
detected via solid phase sandwich enzyme linked immunosor-
bent assay, while inducible nitric oxide synthase activity was
determined via competitive enzyme immunoassay (ALPCO
Diagnostics, USA).
2.6. Antioxidant biomarkers in jejunal homogenates
Jejunal reduced glutathione level was determined colorimetri-
cally via precipitation of proteins using tungstate sulfuric acid
solution and the formation of a yellow color after reaction with
DNTB (Prins and Loose, 1969), while, the activity of glu-
tathione peroxidase was determined kinetically depending on
the catalyzing potential of GPX to reduce H2O2 and to oxidize
reduced glutathione forming oxidized glutathione (GSSG)
which in turn is reduced by glutathione reductase and NADPH
forming NADP+ resulting in a decreased absorbance of
solution at 340 nm. This decrease in absorption is directly pro-
portional to GPX activity (Paglia and Valentine, 1967). Also,
total antioxidant capacity of jejunum tissue was determined col-
orimetrically via its activity to eliminate certain amounts of
exogenously added H2O2. Residual amounts of H2O2 are enzy-
matically determined yielding colored products (Koracevic
et al., 2001). To determine the catalase activity, we used the
method of Aebi (1984) which is based on the catalytic activities
of catalase on a known amount of H2O2 for a certain time, and
then reaction is stopped using a catalase inhibitor. The remain-
ing amounts of H2O2 are determined colorimetrically in the
presence of peroxidase enzyme and DHBS and aminophena-
zone to form a chromophore with the color intensity inversely
proportional to the amount of catalase in the original sample.
2.7. Statistical analysis
Statistical analysis was carried out by using an unpaired
Student’s t-test. The obtained data were analyzed by MS Excel
2007 (Microsoft, Rochester, NY, USA) and SigmaPlot 2011
(Systat Software, Inc., Chicago, IL, USA).
3. Results
Berberine treatment caused a significant reduction in the
number of apoptotic cells (P 6 0.05) within the jejunum tissuenal antioxidant status of laboratory mice, Mus musculus. Saudi Journal of Bio-
Figure 1 Berberine induced reduction of apoptotic cell number within jejunum villous tissue in laboratory mice, Mus musculus. All
values are mean ± SD. *Significant against control non-treated group at P 6 0.05.
Table 1 Effect of berberine administration on jejunal glutathione peroxidase activity, catalase activity and reduced glutathione and
total antioxidant capacity in laboratory mice.
Glutathione peroxidase (mU/g) Reduced glutathione (lmol/g) Catalase (U/g) Total antioxidant capacity (mM/g)
Control 86.5 ± 12.1 1.3 ± 0.15 0.3 ± 0.07 1.2 ± 0.16
BBR-treated 147.8 ± 10.9* 1.8 ± 0.11* 0.79 ± 0.25* 2.6 ± 0.3*
All values are mean ± SD.
* Significant against non-treated control group at P 6 0.05.
Figure 2 Berberine induced reduction of oxidized protein level within jejunum tissue of laboratory mice, Mus musculus. All values are
mean ± SD. *Significant against control non-treated group at P 6 0.05.
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4 M.A. Dkhil et al.from 15.5 ± 2.3 to 8.3 ± 2.6 apoptotic cell/10 VCU
(Figs. 1 and S1).
Upon oral administration of berberine to mice, a great
enhancement of the antioxidant system within the jejunum tis-
sue occurred. The total antioxidant capacity of jejunum tissues
was raised by more than two fold (Table 1). Also, reduced glu-
tathione level was increased to 1.8 lmol/g (Table 1). In addition,
the antioxidant enzyme GPX was duplicated (Table 1) and that
of CAT activity was increased by more than two fold (Table 1).
Oxidative damage biomarkers in the infected jejunum tissue
were significantly decreased after berberine treatment.
Oxidized protein level was decreased by more than 50%
(Fig. 2). In addition, nitrite/nitrate level was reduced to 302Figure 3 Berberine induced reduction of nitrite/nitrate level within
mean ± SD. *Significant against control non-treated group at P 6 0.0
Figure 4 Berberine induced reduction of lipid peroxidation products
are mean ± SD. *Significant against control non-treated group at P 6
Please cite this article in press as: Dkhil, M.A. et al., Berberine improves the intesti
logical Sciences (2015), http://dx.doi.org/10.1016/j.sjbs.2015.10.012± 52 lmol/g (Fig. 3). Malondialdehyde and hydrogen perox-
ide contents were decreased to 25.6 nmol/g and 3.0 mM/g,
respectively after berberine treatment (Figs. 4 and 5). Also,
the activity of the pro-inflammatory cytokine (TNF-a) and
inducible nitric oxide synthase (iNOs) was decreased from
233.6 pg/g and 46.2 pmol/g to 168 pg/g and 32.4 pmol/g,
respectively (Figs. 6 and 7).
4. Discussion
Pro-oxidants cannot be avoided in our food but we need to
make sure that they are made by consumption of naturally
formed antioxidants (Surai et al., 2004). Antioxidants arejejunum tissue of laboratory mice, Mus musculus. All values are
5.
within jejunum tissue of laboratory mice,Mus musculus. All values
0.05.
nal antioxidant status of laboratory mice, Mus musculus. Saudi Journal of Bio-
Figure 5 Berberine induced reduction of hydrogen peroxide level within jejunum tissue of laboratory mice,Mus musculus. All values are
mean ± SD. *Significant against control non-treated group at P 6 0.05.
Figure 6 Berberine induced reduction of the pro-inflammatory cytokine (TNF-a) level within jejunum tissue of laboratory mice, Mus
musculus. All values are mean ± SD. *Significant against control non-treated group at P 6 0.05.
Improvement of the intestinal antioxidant status of mice 5essential for the gastrointestinal tract (GIT) to prevent lipid
peroxidation. Also, antioxidant enzymes are needed in the
intestinal mucosa to fight the induced oxidative damage
(Srigiridhar and Nair, 1997). Disturbance of the antioxidant
system of the GIT could lead to various diseases as cells
become more susceptible to infections by various microorgan-
isms or the loss of their function in food absorption.
Experimental mice treated with berberine showed a great
enhancement in the antioxidant status of their intestinal tissue.
The activity of glutathione peroxidase and catalase enzymes
was elevated, the glutathione level reduced and the total
antioxidant capacity was also increased (Table 1). Also,
lipid peroxidation and protein oxidation processes werePlease cite this article in press as: Dkhil, M.A. et al., Berberine improves the intestin
logical Sciences (2015), http://dx.doi.org/10.1016/j.sjbs.2015.10.012significantly diminished as revealed by the decreased amounts
of malondialdehyde and protein carbonyl contents after ber-
berine treatment (Figs. 2 and 4. Moreover, hydrogen peroxide
level was significantly reduced by about half of its value in
control non-treated mice (Fig. 5). Finally, berberine effectively
down-regulated nitric oxide pathway of inflammation as
revealed by the decreased amounts of the pro-inflammatory
cytokine (TNF-a) (Fig. 6), decreased activity of inducible nitric
oxide synthase enzyme (Fig. 7) and reduced nitrite/nitrate
levels within the jejunum tissue (Fig. 3).
Berberine was found to have a great capacity for quenching
different free radicals such as DPPH, O2
, NO and OH
(Hwang et al., 2006; Siow et al., 2011). It could decrease theal antioxidant status of laboratory mice, Mus musculus. Saudi Journal of Bio-
Figure 7 Berberine induced reduction of inducible nitric oxide synthase activity within jejunum tissue of laboratory mice,Mus musculus.
All values are mean ± SD. *Significant against control non-treated group at P 6 0.05.
6 M.A. Dkhil et al.formation of malondialdehyde in cultured rat hepatocytes with
prevention capacity on the depletion of glutathione (Altman
et al., 1994; Hwang et al., 2006; Thirupurasundari et al.,
2009). It also caused downregulation of the gene expression
ratio of inflammatory biomarkers such as TNF-a and iNOs
(Choi et al., 2006; Kim et al., 2007, 2008; Lou et al., 2011;
Domitrovic´ et al., 2013). In addition, berberine has a wide
range of antioxidant activities including activation of the
antioxidant enzyme systems of SOD, CAT, GST and GPX,
with conservation activities of non-enzymatic antioxidant
levels (Siow et al., 2011; Domitrovic´ et al., 2013).
BBR protective activities against oxidative and cytotoxic
damage occur via activation and/or suppression of different
cellular pathways. It could inhibit inducible cyclooxygenase-2
(COX-2) over production through the activation of Peroxisome
proliferator-activated receptor-gamma (PPARc) pathway
(Feng et al., 2012), and suppress b-phosphorylation processes
leading to diminished production of IL-1b and TNF-a (Lee
et al., 2007). In addition, its inhibitory effect of nitric oxide pro-
duction and iNOs expression occurs via AMP-activated protein
kinase sensitive pathway (Siow et al., 2011). It was also found
to inhibit ROS production through the inhibition of
NADPH-oxidase mediated O2
 release (Siow et al., 2011).
Moreover, it caused the activation of redox sensing transcrip-
tion factor Nrf2 and inhibition of NF-jb dependent proinflam-
matory mediator’s production of iNOs, COX-2 and TNF-a
(Chitra et al., 2013).
Apoptosis in the gastro intestinal system is vitally essential,
where constant and rapid renewal of intestinal cells is in pro-
gress providing normal function holding tissue homeostasis.
In addition, many factors contribute to apoptosis including
the elevated reactive oxygen and nitrogen intermediates and
inflammatory cytokines within cells (Ramachandran et al.,
2000; Major et al., 2011).
Results of the current study show that berberine treatment of
normal mice induced protection of villous epithelial cells from
apoptotic changes as it caused a decrease in the number ofPlease cite this article in press as: Dkhil, M.A. et al., Berberine improves the intesti
logical Sciences (2015), http://dx.doi.org/10.1016/j.sjbs.2015.10.012apoptotic cells by about 50% (Figs. 1 and S1). This prevention
of apoptosis may be due to the downregulatory effects of berberine
on Bax/Bcl-2 gene expression ratio (Chueh and Lin, 2012a,b).
Collectively, our data show that berberine treatment induced
a significant enhancement of intestinal health in laboratorymice
as revealed by decreasing apoptotic changes and reducing
oxidative damage biomarkers with great activation of antioxi-
dant biomarkers. So, it is recommended to use berberine in food
or drug mixtures to enhance the intestinal health status.Acknowledgement
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